Biomedical subjects

N C Nyborg

Publications and source records attributed to N C Nyborg.

60 records · Page 4Linked to original sources

PubMed1984

A novel principle for detection of systolic and diastolic blood pressure tested in man and rat with special reference to its applicability in rat studies.

A non-invasive procedure for the application of a photodetector method in rat studies to obtain both systolic and diastolic blood pressure measurements is described. The method has been tested against well-established procedures in rats and in human beings and has proved sufficiently fast and reliable for use in long-term studies. Regression analysis of simultaneously obtained invasive versus non-invasive measurements yielded correlation coefficients of 0.99 and 0.98 respectively. Comparison with the Korotkoff principle in human beings yielded correlation coefficients of 0.96 and 0.78 respectively.

Animals↗

PubMedDate not supplied

Effect of felodipine, a new dihydropyridine vasodilator, on contractile responses to potassium, noradrenaline, and calcium in mesenteric resistance vessels of the rat.

The effect of felodipine [4-(2,3-dichloro-phenyl)-1,4-dihydro-2,6-dimethyl-3-ethoxycarbonyl-5- methoxycarbonylpyridine on the contractile responses of mesenteric resistance vessels denervated in vitro was investigated. Sustained contractions of this vessel type were totally dependent on extracellular calcium. Felodipine (10-(15)-10-(9)M) had a concentration-dependent inhibitory action on contraction induced by maximal potassium (125 mM) and noradrenaline (10-(5)M) stimulation. Felodipine was more potent and more selective than D600 and nifedipine. Potassium and noradrenaline concentration-response characteristics were insurmountably antagonized by felodipine, the potassium sensitivity of vessels being unaffected while noradrenaline sensitivity was decreased. In calcium-depleted vessels, felodipine in all concentrations tested produced insurmountable antagonism of the potassium-activated calcium concentration-response characteristics, whereas the antagonism in low concentrations (10-(15)-10-(11)M) was surmountable in noradrenaline-activated vessels. Felodipine 10-(9) M blocked the response of potassium-activated vessels almost completely, whereas approximately 50% of the response of noradrenaline-activated vessels persisted. The results of this investigation indicate that the effect of felodipine may be caused primarily by selective inhibiton of responses evoked by membrane depolarization.

Animals↗

PubMedDate not supplied

In vitro studies on responses to noradrenaline, serotonin, and potassium of intramyocardial and mesenteric resistance vessels from Wistar rats.

We compared the responses to noradrenaline, serotonin, and potassium of isolated intramyocardial (flow-regulating) coronary and mesenteric resistance vessels of similar internal diameter (approximately 200 microns) from Wistar rats. The coronary but not the mesenteric resistance vessels had spontaneous basal tone, which was reduced by elimination of extracellular calcium, by increasing the extracellular potassium concentration up to 22 mM, and by stimulation of coronary vessels with noradrenaline. Noradrenaline always caused contraction of mesenteric resistance vessels and in coronary vessels after incubation with propranolol (3 X 10(-6) M). The noradrenaline and potassium concentration-response characteristics of the mesenteric resistance vessels were modulated by perivascular adrenergic nerve terminals, whereas no influence of nerve terminals could be shown in the coronary resistance vessels. The sensitivity of mesenteric vascular smooth muscle to noradrenaline [concentration required to give half maximal response (EC50) approximately 0.4 X 10(-6) M] and serotonin (EC50 approximately 0.3 X 10(-6) M) was higher (p less than 0.001) than the sensitivity of coronary smooth muscle (EC50 values 1.6 X 10(-6) and 1.3 X 10(-6) M, respectively). The potassium sensitivity of the coronary smooth muscle (EC50 approximately 35 mM) was higher than that of the mesenteric smooth muscle (EC50 approximately 41 mM; p less than 0.01). The respective maximal noradrenaline and serotonin responses relative to the maximal potassium response were 35 and 55% in the coronary and 127 and 120% in the mesenteric resistance vessels (p less than 0.001).

Animals↗

PubMedDate not supplied

Characterization of beta-adrenoceptor subtype in isolated ring preparations of intramural rat coronary small arteries.

We characterized the beta-adrenoceptor subtype in isolated ring preparations of small intramyocardial flow-regulating (resistance) arteries (i.d. congruent to 239 micrometers) from rats by using beta 2 adrenoceptor agonists and beta-adrenoceptor antagonists exhibiting selectivity towards either beta 1- (pafenolol) or beta-adrenoceptors (ICI 118,551). The relative order of potency of selected agonists in producing beta-adrenoceptor-mediated relaxation of prostaglandin F2 alpha (10(-5) M) contracted coronary vessels was: isoprenaline greater than noradrenaline = adrenaline. ICI 118,551, but not pafenolol, relaxed coronary resistance vessels precontracted with prostaglandin F2 alpha (10(-5) M) or high potassium (125 mM) solutions. The IC50 values were 8.59 x 10(-6) M and 2.96 x 10(-5) M, respectively (p less than 0.0005). This indicates that ICI 118,551 had membrane-stabilizing effects. Both ICI 118,551 and pafenolol antagonized in a concentration-dependent manner the isoprenaline-induced relaxation of prostaglandin F2 alpha (10(-5) M) contracted coronary resistance vessels. The slopes and regression lines of the Schild plots were not significantly different from unity and the calculated pA2 values were 7.55 and 6.59 (p less than 0.005) for pafenolol and ICI 118,551, respectively. The results are compatible with the suggestion that beta-adrenoceptors mediating relaxation in rat coronary resistance vessels belong to the beta 1-adrenoceptor subtype.

Adrenergic beta-Antagonists↗

PubMedDate not supplied

Comparison of the effects of the vasoconstrictive dihydropyridines BAY K 8644 and CGP 28392 on isolated rat aorta: different sensitivities to ultraviolet radiation.

The effect of BAY K 8644 was compared to that of CGP 28392 in isolated rat thoracic aorta. In low concentration both dihydropyridines had a direct concentration dependent contractile effect that could be eliminated in Ca-free medium and by the Ca-antagonist nifedipine. Readdition of Ca to the Ca-free medium restored the contractile response to both agents. In high concentrations (greater than or equal to 10(-5) M), both agents depressed active tone. In physiological salt solution containing 15.8 mM, potassium BAY K 8644 was far more potent in contracting rat aorta than CGP 28392. The responses to BAY K 8644 and CGP 28392 were not affected by alpha- and beta-adrenoceptorblockade. Both compounds shifted the noradrenaline- and potassium-concentration response curve to the left and increased the maximal response. Ultraviolet radiation (UVR) had a reversible and marked effect on BAY K 8644 and no effect on CGP 28392 contractions. The UVR-mediated relaxation of BAY K 8644-induced contractions could partly be eliminated by raising extracellular Ca. The results showed that differences according to potency and mode of action exist between BAY K 8644 and CGP 28392 in rat aorta. To explain the effect of UVR on BAY K 8644-induced contractions, a modification of a Ca channel model is proposed that implies the existence of "photosensitive proteins" located to "Ca antagonist" binding sites. According to this hypothesis, UVR may induce a reversible binding of BAY K 8644 to "Ca antagonist receptors."

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethy↗

PubMedDate not supplied

Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats.

We have examined the effect of antihypertensive treatment on heart weight and on structural and functional characteristics of isolated mesenteric resistance vessels (internal diameter 170-220 micron) in spontaneously hypertensive rats (SHR) and in Wistar-Kyoto rats (WKY). The SHR and WKY were treated with hydralazine from the age of 4 weeks and were examined at ages 12 to 14 weeks and 23 to 27 weeks. Treated SHR had a mean blood pressure as much as 29% below that of control WKY, which in turn was 25 to 40% less than that of control SHR. In 12- to 14-week-old rats the heart to body weight ratio (which in control SHR was 13% greater than of WKY) was unaffected by treatment. Thereafter, the heart to body weight ratio of treated SHR did not increase as much as usual. At both ages, the media thickness and contractile response of the resistance vessels of the SHR (which were, respectively, 37% and 30% greater than those of vessels of WKY) were unaffected by treatment. However, because treatment caused a small (8%) increase in the lumen diameter of the vessels of the SHR, treatment did cause small, but possibly physiologically important, decreases both in the media to lumen ratio (11%) and in the pressure against which these vessels would have been able to contract (10%). Treatment had little effect on the pharmacological characteristics of vessels of either SHR or WKY. The results suggest that the increased heart weight, media thickness, and contractile response in mesenteric resistance vessels of SHR up to ages 23 to 27 weeks are due primarily to factors other than increased pressure.

Aging↗